Pacific Biosciences of California Inc. sell StockNews.com
Start price
29.12.23
/
50%
€9.37
Target price
29.12.24
-
Performance (%)
-80.07%
Price
17.05.24
€1.87
Summary
This prediction is currently active. The SELL prediction by StockNews_com for Pacific Biosciences of California Inc. is performing very well with a performance of -80.07%. This prediction currently runs until 29.12.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | 13.278% | 13.278% |
iShares Core DAX® | -0.383% | 5.021% |
iShares Nasdaq 100 | 1.248% | 4.007% |
iShares Nikkei 225® | 0.525% | -0.109% |
iShares S&P 500 | 0.640% | 3.649% |
Comments by StockNews_com for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PACB provided by MarketBeat
Stopped prediction by StockNews_com for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.39
18.04.24
18.04.24
-
18.04.25
18.04.25
34.31%
17.05.24
17.05.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€3.86
12.03.24
12.03.24
-
12.03.25
12.03.25
-51.67%
17.05.24
17.05.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€5.85
13.01.24
13.01.24
-
13.01.25
13.01.25
-68.09%
17.05.24
17.05.24